Neurodegenerative Diseases: current treatment algorithm and potential investment opportunities covered in a lates research report

This report examines the entire neurodegenerative disease therapy area, with a particular focus on the three most prevalent neurodegenerative disorders: Alzheimer’s disease (AD), Parkinson’s disease (PD) and multiple sclerosis (MS).

Pune, India - March 14, 2018 /MarketersMedia/ —

AD and PD represent the most pressing challenges within the disease cluster, due to rapidly increasing prevalence driven by aging populations. Both AD and PD remain ineffectively treated despite substantial investment into R&D by pharmaceutical companies, due to high clinical trial failure rates. As a result there are no disease-modifying therapies for these two indications, with available treatments able to provide only marginal symptomatic relief. MS, the autoimmune disease of the CNS, contrasts with the rest of this cluster, as it affects a different population demographic, and has a lucrative pharmacological market following breakthrough success in the past decade.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-neurodegenerative-diseases-protein-misfolding-targets-and-neuromodulators-dominate-the-first-in-class-pipeline-and-lead-the-way-as-potential-disease-modifying-therapies-in-ad-and-pd
Reasons To Buy
• Appreciate the current clinical and commercial landscapes by considering disease symptoms, pathogenesis, etiology, co-morbidities and complications, epidemiology, diagnosis, prognosis and treatment options.
• Identify leading products and key unmet needs within the market.
• Recognize innovative pipeline trends by analyzing therapies by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using proprietary matrix assessments, first-in-class targets in the pipeline have been assessed and ranked according to clinical potential. Individual matrix assessments are provided for targets categorized into four major classes: protein misfolding, neuromodulators, immunomodulators and neuroprotectants. The most promising first-in-class targets are reviewed in greater detail.
• Consider first-in-class pipeline products with no prior involvement in licensing and co-development deals, which may represent potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/935553
Scope
• Unmet need is extremely high in AD and PD, with MS showing continued promise in the development of effective therapies
• What are the most important etiological risk factors and pathophysiological processes implicated in AD, PD and MS?
• What is the current treatment algorithm?
• How effective are current therapies for these indications, and how does this impact prognosis?
• The AD pipeline is large and contains a very high proportion of first-in-class product innovation.
• Which molecule types and molecular targets are most prominent across AD, PD and MS?
• What are the connections, in terms of first-in-class innovation, between AD, PD and MS?
• Which first-in-class targets are most promising?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935553

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/neurodegenerative-diseases-current-treatment-algorithm-and-potential-investment-opportunities-covered-in-a-lates-research-report/314330

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-neurodegenerative-diseases-protein-misfolding-targets-and-neuromodulators-dominate-the-first-in-class-pipeline-and-lead-the-way-as-potential-disease-modifying-therapies-in-ad-and-pd%20

Source: MarketersMedia

Release ID: 314330

More News From Daily Xtreme

Hamilton wins German GP as rival Vettel crashes late on

Jul 22, 2018

HOCKENHEIM, Germany — Lewis Hamilton regained the championship lead in unexpected and dramatic fashion on Sunday, winning the German Grand Prix after Sebastian Vettel crashed while leading near the end. Heavy rain played havoc late on at the Hockenheimring as Vettel misjudged a basic entry into a turn and slid over the gravel into the barriers with 15 laps to go. The four-time Formula One champion started from pole position and seemed in control. He was livid with himself, kicking the gravel in frustration as he stepped out his car. His mishap opened the door wide open for Hamilton, who...

Hamilton's woes piling up after qualifying run ends early

Jul 22, 2018

HOCKENHEIM, Germany — Crouching down by the side of his Mercedes, Lewis Hamilton lowered his head and stayed perfectly still for several moments. The British driver looked lost in thought, deep in contemplation, seemingly unable to believe what happened on Saturday. A hydraulic failure had just ended his qualifying run prematurely, dropping Formula One's all-time record-holder for pole positions to 14th on the grid for Sunday's race. Hamilton's hopes of winning a record-equaling fourth German Grand Prix — and matching Michael Schumacher— have been dented. And his woes are piling up as he duels with Sebastian Vettel — in a...

Verstappen sets new lap record in second German GP practice

Jul 22, 2018

HOCKENHEIM, Germany — Max Verstappen set a new lap record in leading the second practice session for the German Grand Prix on Friday. The 20-year-old Dutch driver clocked 1 minute, 13.085 seconds to eclipse veteran Kimi Raikkonen's time of 1:13.78 from 2004. Verstappen also made it a Red Bull 1-2, after his teammate Daniel Ricciardo was best in the first practice before drifting back in the afternoon. Lewis Hamilton was second quickest in both sessions. His Mercedes teammate Valtteri Bottas finished third in the second practice, with championship leader Sebastian Vettel's Ferrari in fourth. After a rocky start to the...

Mercedes gives Valtteri Bottas 1-year contract extension

Jul 22, 2018

HOCKENHEIM, Germany — Mercedes has given Formula One driver Valtteri Bottas only moderate backing by offering him a new one-year contract. Although Bottas has the option for an extra year in 2020, the Finnish driver will have to prove he deserves it with strong performances in 2019. Mercedes announced the deal on Friday, one day after Formula One champion Lewis Hamilton agreed a two-year contract until 2020. It ends mounting speculation over the short-term future of both of its drivers. The deals were announced at the German Grand Prix with the F1 season reaching its halfway point, and with the...

Hamilton thanks Mercedes for being patient over his new deal

Jul 22, 2018

HOCKENHEIM, Germany — Formula One champion Lewis Hamilton thanked Mercedes for indulging him as he finally signed a new contract, ending months of stalling and growing speculation over his future. With his previous contract set to expire at the end of this year, the four-time world champion penned a new agreement until 2020, when the current set of F1 regulations end. No figures were given, but the bumper deal is reportedly estimated at 40 million pounds ($52 million) per year. Talks began early this year with Toto Wolff, the team's head of motorsport. Hamilton negotiates his own deals and, by...

NHL Livescore